Chugai Commits $220M Into Singapore Drug Lab Post author:Sam Post published:December 28, 2017 Post category:BioPharma The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace You Might Also Like Janssen to Terminate Simeprevir License With Medivir, Effective June 2018 December 10, 2017 How This Drug Candidate Could be a Winner in Gilead's Pipeline March 20, 2017 Merck & Co. is Looking to Hire Many Scientists at BIO in San Diego May 22, 2017
